-
Vaccines, Blood & Biologics
-
Resources for You
-
-
Boostrix
Proper Name: Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed
Tradename: Boostrix
Manufacturer: GlaxoSmithKline Biologicals, License #1617
Indication:
- Booster immunization against tetanus, diphtheria and pertussis as a single dose in adolescents 10-64 years of age
-
Supporting Documents
- December 4, 2008 Approval Letter - Boostrix
Supplement BLA: To include single booster dose in adults 19-64 years of age for active immunization against tetanus, diphtheria, and pertussis. - December 29, 2005 Approval Letter - Boostrix
Package Insert Revision: Include addition of clinical safety information to the package insert. - May 3, 2005 Approval Letter - Boostrix
Indication: Booster immunization against tetanus, diphtheria and pertussis as a single dose in adolescents 10-18 years of age.
-
-
-